FDA Approves TAVR for Low-risk Patients Creates a Paradigm Shift in Cardiology

FDA opened transcatheter aortic valve replacement (TAVR) to low-risk patients with the simultaneous approvals of Edwards Lifesciences' | Feature | Heart Valve Technology | Jeff Zagoudis and Dave Fornell, Diagnostic and Interventional Cardiology (DAIC)

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.